Company Overview and News

 
Warning over impact of alleged fake honey on Australia's bees and crops

2018-09-10 theage.com.au
Key horticulture figures have echoed concerns about the need for a vibrant Australian beekeeping industry that provide bees to pollinate crops, in the wake of tests from a German lab which found that some honey sold in Australia was deemed adulterated.
SHVTF SHV

 
Warning over impact of alleged fake honey on Australia's bees and crops

2018-09-10 smh.com.au
Key horticulture figures have echoed concerns about the need for a vibrant Australian beekeeping industry that provide bees to pollinate crops, in the wake of tests from a German lab which found that some honey sold in Australia was deemed adulterated.
SHVTF SHV

 
Select Harvests Ltd. 2018 Q4 - Results - Earnings Call Slides

2018-08-27 seekingalpha
The following slide deck was published by Select Harvests Ltd. in conjunction with their 2018 Q4 earnings call.
SHVTF SHV

 
Higher almond prices drive Select Harvests' profit up

2018-08-27 theage.com.au
Higher almond prices, a bigger crop and productivity gains helped drive a big jump in the net profit of Australian-listed almond producer Select Harvests, as it warned that climbing water prices were a concern.
SHVTF SHV

 
Higher almond prices drive Select Harvests' profit up

2018-08-27 smh.com.au
Higher almond prices, a bigger crop and productivity gains helped drive a big jump in the net profit of Australian-listed almond producer Select Harvests, as it warned that climbing water prices were a concern.
SHVTF SHV

2
Daniel Kieser: Investors need to seriously chew over synthetic food

2018-06-25 nzherald.co.nz
In the past few decades, we've seen social media disrupt the news industry, electric technology disrupt the automotive industry and online market places disrupt the retail industry.
SHVTF SHV PGWFF PGW PGWFY

 
Webster activates almond plan as global crunch looms

2018-03-16 theage.com.au
Listed agribusiness house Webster looks to have well timed its $16.8 million purchase of a Riverina almond farm, with global supply constraints expected to push up depressed prices for the popular nut and – ultimately – orchard valuations.
SHVTF SHV RFF

 
Webster activates almond plan as global crunch looms

2018-03-16 smh.com.au
Listed agribusiness house Webster looks to have well timed its $16.8 million purchase of a Riverina almond farm, with global supply constraints expected to push up depressed prices for the popular nut and – ultimately – orchard valuations.
SHVTF SHV RFF

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...